Professor of Clinical Pharmacology at Barts and the London School of Medicine and Dentistry.
Sir Mark graduated in Medicine in 1984 from the London Hospital Medical College and trained in Clinical Pharmacology at St Bartholomew’s Hospital (Barts) where he developed a research programme in molecular genetics of hypertension and clinical research. In 2009 he won the Lily Prize of the British Pharmacology Society. He is a Fellow of The Royal College of Physicians.
In 2000 Sir Mark successfully bid for £3.1m to create the Barts and The London Genome Centre at the Queen Mary University of London. Since 2008 he has directed the Barts National Institute of Health Research (NIHR) Cardiovascular Biomedical Research Unit. In 2012 he become Co-Chair of NIHR Comprehensive Research Network Cardiovascular Sub-Speciality Group.
See also: Genomics England - Genomics England was set up to deliver the 100,000 Genomes Project
Mark Caulfield News
New era of prescribing medicines: new genetic test finds out better and safer drugs
BBC - 29-Mar-2022
NHS to roll out genetic test that is currently able to match 40 drugs to patient's genetic codeRead more...
World's largest gene sequencing project in healthcare
BBC - 05-Dec-2018
100,000 Genomes Project has ended "diagnostic odyssey" for 1 in 4 participants with rare diseasesRead more...
Routine cancer DNA tests coming to NHS
Guardian - 03-Jul-2018
NHS establishes a network of specialized centres for DNA analysis for "specialized medicine"Read more...